RESPIRI LTD logo

RESPIRI LTD (RSHUF)

Market Closed
OTCQB OTCQB
$
$
91.52M Market Cap
- P/E Ratio
- Div Yield
- Volume
- Eps
$
Previous Close
Day Range
0 0
Year Range
0 0
Want to track RSHUF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

RSHUF is not paying dividends to its shareholders.
The last earnings report, released on Feb 26, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTCQB (USD).

RSHUF Chart

Similar

CytoDyn Inc.
$ 0.28
-3.45%
Cell MedX Corp.
$ 0.26
-29.12%
Arch Biopartners Inc.
$ 0.91
-1.52%

RESPIRI LTD (RSHUF) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

RESPIRI LTD is listed on OTCQB.

What is its stock symbol?

The ticker symbol is RSHUF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 91.52M.

Has RESPIRI LTD ever had a stock split?

No, there has never been a stock split.

RESPIRI LTD Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Marjan Mikel B.Sc., M.A.I.C.D. CEO
OTCQB Exchange
AU000000RSH4 ISIN
Australia Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Respiri Limited is an innovative e-health SaaS (Software as a Service) company that primarily operates in Australia and the United States. With a focus on researching, developing, and commercializing medical devices, Respiri Limited shines in the e-health industry through its creation of advanced technology aimed at managing respiratory conditions. Initially founded in 1987, the company underwent a significant rebranding from its former identity, iSonea Limited, to Respiri Limited in December 2015. The corporate headquarters is located in Melbourne, Australia, positioning the company at the heart of Australia's bustling tech and healthcare innovation scene.

Products and Services

  • wheezo
  • wheezo is a flagship product designed by Respiri Limited to effectively detect wheezing rates. This device is groundbreaking in its capability to catch and analyze the sound of a wheeze, which is a common symptom in conditions such as asthma. The easily portable and user-friendly nature of wheezo makes it a valuable tool for individuals needing to monitor their respiratory condition closely.

  • Respiri Mobile Application
  • The Respiri Mobile Application works hand-in-hand with the wheezo device, providing a seamless interface for users to interact with their wheeze data. This application not only records wheeze detection data but also offers insightful analytics and personalized feedback based on the user’s respiratory health over time. Such features empower users with detailed understanding and management of their condition.

  • Respiri Health Portal
  • The Respiri Health Portal extends the company's service offering into a web-based platform, providing a comprehensive dashboard for both patients and healthcare providers. This portal plays a crucial role in ensuring that relevant health data is accessible, understandable, and actionable. By facilitating a stronger connection between patients and healthcare providers, the Respiri Health Portal enhances the overall efficacy of respiratory health management.

Contact Information

Address: 432 St Kilda Road
Phone: 61 3 9653 9160